Fair Money & Economic Opportunity

Helius Medical Technologies, Inc. is a neurotechnology company focused on developing and commercializing neurological rehabilitation devices, not a financial institution.

The value 'Fair Money & Economic Opportunity' primarily assesses financial institutions and their activities related to lending, insurance, moving, or storing money. As Helius Medical Technologies does not offer consumer financial services, such as lending or deposit accounts, the quantitative thresholds and definitions for all KPIs within this value are not applicable to its core business model. While the company's medical device can lead to positive economic outcomes for patients (e.g., returning to work), these are not direct outcomes of financial products or services as defined by the rubric. Therefore, no KPIs can be scored based on the provided evidence.

Fair Trade & Ethical Sourcing

The company's manufacturers received Conflict Minerals Reporting Template (CMRT) responses from more than 50% of their surveyed suppliers.

However, these CMRTs were company-wide and not specific to the PoNS device, explicitly limiting traceability for Helius. The company's manufacturers reported that they require their direct suppliers to be DRC conflict-free. The company relies on its manufacturers' supply chain surveys and CMRTs, but the frequency of these audits is not specified. There is no information regarding fair-trade certifications, forced or child labor incidents, remediation speed, materials risk, or supplier diversity spend.

No War, No Weapons

Helius Medical Technologies, Inc. (HSDT.US) has a conflict minerals policy and conducts due diligence to comply with Rule 13p-1 under the Securities Exchange Act of 1934.

The company uses a third-party service provider for supply chain due diligence and reporting, aligning with OECD Due Diligence Guidance. Their 2022 report indicates a 60% response rate from 689 in-scope suppliers. Of the identified smelters/refiners, 224 are RMAP conformant, 8 are RMAP active, 89 are not enrolled, and 24 are non-conformant. The report acknowledges inherent risks of incomplete or inaccurate data and tracks program gaps for improvement.

Zero Waste & Sustainable Products

No specific, quantitative data regarding HSDT.US's waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability scores, waste audit frequency, zero-waste certifications, waste disposal violations, material efficiency, packaging-to-product ratios, waste reduction targets, supplier waste requirements, or customer waste education was found in the provided articles.

The articles explicitly state significant data gaps concerning HSDT.US's specific sustainability practices.